Back
Avidity Biosciences Vs. Dyne Therapeutics Industry Stock Comparison
Sell
38
RNA
Avidity Biosciences
Last Price:
$29.99
Seasonality Move:
-7.99%
Sell
10
DYN
Dyne Therapeutics
Last Price:
$11.49
Seasonality Move:
-6%
Sell
38
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $30.29. The Score for RNA is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
10
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy, Sell or Hold?
-
The current Dyne Therapeutics [DYN] share price is $12.40. The Score for DYN is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
-
DYN is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $30.29Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing slight buying pressure.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $12.40Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing slight selling pressure.
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.69 | Sell |
Relative Strength Index (14 RSI): | 46.73 | Sell |
Chaikin Money Flow: | 252968 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.87 - 33.73) | Sell |
Bollinger Bands (100): | (29.77 - 43.83) | Sell |
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.14 | Sell |
Relative Strength Index (14 RSI): | 35.17 | Sell |
Chaikin Money Flow: | -19100 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.72 - 14.92) | Sell |
Bollinger Bands (100): | (15.54 - 30.7) | Sell |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.69 | Buy |
20-day SMA: | 31.48 | Sell |
50-day SMA: | 30.97 | Sell |
200-day SMA: | 38.55 | Sell |
8-day EMA: | 30.05 | Buy |
20-day EMA: | 30.76 | Sell |
50-day EMA: | 32.3 | Sell |
200-day EMA: | 34.11 | Sell |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.7 | Sell |
20-day SMA: | 13.64 | Sell |
50-day SMA: | 16.44 | Sell |
200-day SMA: | 30.15 | Sell |
8-day EMA: | 12.66 | Sell |
20-day EMA: | 13.54 | Sell |
50-day EMA: | 16.75 | Sell |
200-day EMA: | 24.62 | Sell |
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.10 per share, a decrease this year of $1.10 per share, and a decrease next year of $0.78 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.07 per share, and a decrease next year of $0.24 per share.
Avidity Biosciences Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dyne Therapeutics Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |